This is a working overview of Ac-LKKTETQ, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Acetylated heptapeptide form |
| Monoisotopic mass | 888.5 Da | Average mass about 889 Da |
| Appearance | White to off-white solid | Usually supplied as lyophilised powder |
| Solubility class | Highly water soluble | Also dissolves in aqueous buffers |
| Common synonyms | Tbeta4 fragment, thymosin beta-4 (17-23) | Refer to the same sequence |
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
Oil money funded social welfare programs, leading to housebuilding projects and improved healthcare and education. House building became a major social priority to eliminate homelessness and replace the shanty towns created by Libya's growing urbanization. The health sector was also expanded; by 1978, Libya had 50 per cent more hospitals than it had in 1968, while the number of doctors had increased from 700 to over 3,000 in that decade. Malaria was eradicated, and trachoma and tuberculosis greatly curtailed. Compulsory education was expanded from 6 to 9 years, while adult literacy programs and free university education were introduced. Beida University was founded, while Tripoli University and Benghazi University were expanded. In doing so, the government helped integrate the poor into the education system. Through these measures, the RCC greatly expanded the public sector, providing employment for thousands. These early social programs proved popular within Libya, partly due to Gaddafi's personal charisma, youth, underdog status as a Bedouin, and his rhetoric emphasizing himself as a successor to the anti-Italian fighter Omar al-Mukhtar. To combat the country's strong regional and tribal divisions, the RCC promoted the idea of a unified pan-Libyan identity. They discredited tribal leaders as agents of the old regime, and in August 1971 a Sabha military court tried many of them for counter-revolutionary activity.
=== Do–Du === George H. Dodd (c. 1942–2020). British biochemist who studied perfumes and pheromones. Edward Adelbert Doisy (1893–1986). American biochemist at St Louis University, known for discovering vitamin K. Nobel Prize in Physiology or Medicine (1943). Ford Doolittle (b. 1942). American biochemist at Dalhousie University, known for contributions to the study of cyanobacteria and of biochemical evolution in general. Member Natl. Acad. Sci. USA. Jonathan Dordick (b. 1959). American biochemical engineer at Rensselaer Polytechnic Institute, known for development of enzyme catalysis under extreme conditions. Ralph Dorfman (1911–1985). American biochemist at Stanford, known for treatments for cancer and rheumatoid arthritis Jennifer Doudna (b. 1964). American biochemist at UC Berkeley, known for CRISPR-mediated genome editing. Member Natl. Acad. Sci. USA. Nobel Prize in Chemistry, 2020. Alexander Dounce (1909–1997). American protein chemist at the University of Rochester, active in early work on the genetic code, one of the first to suggest that it was triplet-based. Gideon Dreyfuss (PhD 1978). American biochemist and biophysicist at the University of Pennsylvania, concerned with the function and biogenesis of non-coding RNA and the proteins that interact with RNA. Member Natl. Acad. Sci. USA. Jack Cecil Drummond FRS (1891–1952). British biochemist at University College London, known for the isolation of Vitamin A, and wartime advisor on nutrition. Murdered in France, with his wife and daughter. Vincent du Vigneaud (1901–1978).
Carbazole 1,9a-dioxygenase (EC 1.14.12.22, CARDO) is an enzyme with systematic name 9H-carbazole,NAD(P)H:oxygen oxidoreductase (2,3-hydroxylating). This enzyme catalyses the following chemical reaction
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda (pembrolizumab), a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".
Sources: en.wikipedia.org
In the meanwhile, Peng Liyuan and Melania Trump visited the Smithsonian Institution’s National Museum of Asian Art, where they spent 45 minutes. Museum director Chase F. Robinson later said Melania had selected the venue. They visited various exhibitions including viewing a jade disk from the Shang dynasty, visiting The Peacock Room, viewing a 18th-century Qianlong-period Chinese porcelain, as well as looking at a scroll painting from the Yuan dynasty. Peng praised the US for its return of Chinese cultural relics to China. Melania and Peng watched American teenagers from the youth choir from Hope Chinese School sing Chinese songs including "Jasmine Flower" and "Songs & Smiles"; Peng encouraged them to continue learning Chinese language and culture. After the meeting finished, Trump said they had a "great meeting" and the two leaders toured the renovated White House grounds including the new Marine One helicopter on the newly constructed helipad. Trump said of Xi, "He likes granite. He’s an expert on stone, aside from many other things, and he loves good granite". Trump also showed Xi the Presidential Walk of Fame, where he showed him the framed "autopen" in place of former president Joe Biden.
==== Hair bleaching and coloring ==== Diluted H2O2 (between 1.9% and 12%) mixed into a solution with aqueous ammonia, aniline (color molecule) and a coupler, has been used to color human hair. It can also be mixed with powder or cream bleach compounds, most notably potassium chloride. Bleaching hair follicles does not destroy or remove color molecule or melanocytes. Bleaching compounds work to drive wedges between color molecules or melanocytes, allowing more visible light to pass through the hair shaft. The chemical's bleaching property lends its name to the phrase "peroxide blonde". Hydrogen peroxide is also used for tooth whitening. It may be found in most whitening toothpastes. Hydrogen peroxide has shown positive results involving teeth lightness and chroma shade parameters. It works by oxidizing colored pigments onto the enamel where the shade of the tooth may become lighter. Hydrogen peroxide may be mixed with baking soda and salt to make a homemade toothpaste.
Currently, therapeutic strategies are being studied to help improve the communication between different cells in this pancreatic region by diving deeper into the cellular functions of these very cells and the regions they islet regions they reside in. The current studies being done mainly focus on diabetes and preventing the adverse effects it poses on mammalian organisms. The studies being done now focus heavily on the potential for stem-cell therapeutics or the development of different pharmaceuticals to help limit this condition.
VOCs can also be introduced from the bodies of the bees, be produced by the enzymatic actions of digestion, or from chemical reactions that occur between different substances within the honey during storage, and therefore may change, increase, or decrease over long periods of time. VOCs may be produced, altered, or greatly affected by temperature and processing. Some VOCs are heat labile, and are destroyed at elevated temperatures, while others can be created during non-enzymatic reactions, such as the Maillard reaction. VOCs are responsible for nearly all of the aroma produced by a honey, which may be described as "sweet", "flowery", "citrus", "almond" or "rancid", among other terms. In addition, VOCs play a large role in determining the specific flavor of the honey, both through the aromas and flavor. VOCs from honeys in different geographic regions can be used as floral markers of those regions, and as markers of the bees that foraged the nectars.
Beyond its store endeavors, Jollibee also ventured into media, notably partnering with GMA for the children's magazine show Chikiting Patrol, which aired from 1996 to 2002. In 1998, Jollibee would expand to North America with its first United States location in Daly City, California. Jollibee first entered Europe in 2018 with the opening of a branch in Milan, Italy.
Sources: en.wikipedia.org
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.
It consists of leucine, lysine, lysine, threonine, glutamic acid, threonine, and glutamine in that order. The N-terminal leucine is usually acetylated in the forms described in catalogues.
Controlled human data is limited, and most published findings come from cell culture or animal work. This makes it difficult to state clinical effects with confidence.
TB-500 is a synthetic heptapeptide corresponding to a fragment of thymosin beta-4. It is used in laboratory research and is not an approved drug.